Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2022-10-28 Regulatory Filings
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Giải trình chênh lệch lợi nhuận sau thuế quý 3/2022 so với quý 3/2021
Regulatory Filings Classification · 84% confidence The document is a regulatory submission to the State Securities Commission and Ho Chi Minh Stock Exchange explaining the variance in Q3 2022 after‐tax profit versus Q3 2021. It contains summary tables and narrative reasons for profit fluctuations, but it is not the full interim financial report itself (lacking complete financial statements), nor is it an AGM material, proxy, or other specialized filing. This aligns with a general regulatory announcement or explanatory note, which falls under the fallback Regulatory Filings category (RNS).
2022-10-28 Vietnamese
DCL: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 24
Board/Management Information Classification · 90% confidence The document is a formal notice to the stock exchange announcing a change in the company’s Certificate of Business Registration, specifically detailing a change in the legal representative and General Director. This constitutes an announcement of senior management changes, matching the Board/Management Information category.
2022-09-07 Vietnamese
DCL: Nghị quyết HĐQT về việc thay đổi Tổng Giám đốc, Người đại diện theo pháp luật của công ty
Board/Management Information Classification · 92% confidence The document is a formal notification of changes in senior management (appointments and dismissals of the CEO and legal representative) issued by the Board of Directors. It contains board resolutions and personnel details, fitting the definition of a Board/Management Information filing.
2022-08-31 Vietnamese
DCL: Giải trình biến động LNST HN bán niên năm 2022 so với cùng kỳ năm trước
Regulatory Filings Classification · 90% confidence The document is a regulatory disclosure by a Vietnamese listed company explaining the half-year profit after tax variance (semiannual 2022 vs 2021) as required by securities rules. It provides a brief table of substantive financial data with explanatory notes but does not present a full interim financial report. This falls under general compliance or regulatory announcements, making it a Regulatory Filing (RNS).
2022-08-29 Vietnamese
DCL: Giấy chứng nhận đăng ký hoạt động chi nhánh Vĩnh Long
Regulatory Filings Classification · 85% confidence The document is a formal regulatory announcement notifying the stock exchange and public of a change in the company branch’s business registration certificate. It does not present financial statements or governance materials, nor is it a meeting or management report. It is a compliance filing announcing administrative changes, fitting the fallback Regulatory Filings category.
2022-08-18 Vietnamese
DCL: Nghị quyết số 14 ngày 29/07/2022
Regulatory Filings Classification · 80% confidence The document is a formal Board of Directors resolution (“Nghị quyết”) approving related-party contracts and delegating authority to the CEO. It does not announce changes in board composition (MANG), report financial results (10-K, IR, ER), detail ESG issues (SR), or represent an investor presentation (IP), proxy solicitation (PSI), or share capital change (SHA/POS). It is an internal corporate governance decision and does not fit any highly specific transactional or financial reporting category, so it defaults to a general regulatory filing. Hence, it is classified as Regulatory Filings (RNS).
2022-08-02 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.